PR Newswire NEW YORK, Dec. 12, 2024 -- New research demonstrates integrating AI-enabled, health record data insights with targeted educational interventions can enhance understanding and management of serious adverse events, such as ...
PR Newswire SHELTON, Conn. and BERN, Switzerland, Dec. 12, 2024 Enrollment is ongoing and seven sites in Switzerland have been activated SHELTON, Conn. and BERN, Switzerland, Dec. 12, 2024 /PRNewswire/ -- Intensity Therapeutics, Inc. ...
PR Newswire FORT MILL, S.C. and RYE BROOK, N.Y., Dec. 12, 2024 The five-year partnership agreement names Sunbelt Rentals as the National Presenting Partner for LLS's philanthropic program Student Visionaries of the Year FORT MILL, S.C. ...
PR Newswire BOSTON, Dec. 12, 2024 -- EO-1022 is comprised of seribantumab, an anti-HER3 monoclonal antibody, and an MMAE payload – -- Following recently signed global license agreement with Synaffix, EO-1022 leverages the company's ...
PR Newswire FLORENCE, Italy and BARCELONA, Spain, Dec. 12, 2024 FLORENCE, Italy and BARCELONA, Spain, Dec. 12, 2024 /PRNewswire/ -- The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline ...
PR Newswire NEW YORK, Dec. 11, 2024 NEW YORK, Dec. 11, 2024 /PRNewswire/ -- A2A Pharmaceuticals, Inc. ("A2A or "the company"), a clinical-stage pioneering biopharmaceutical company focused on developing innovative cancer therapies, today ...
PR Newswire INDIANAPOLIS, Dec. 11, 2024 As monotherapy, imlunestrant significantly reduced the risk of progression or death by 38% compared to standard endocrine therapy (ET) in patients with ESR1 mutations As combination therapy, ...
PR Newswire PLYMOUTH MEETING, Pa., Dec. 11, 2024 The National Comprehensive Cancer Network's Oncology Research Program's grant will advance scientific knowledge of hematologic toxicity of PARPi in the treatment of patients with prostate ...
PR Newswire SYDNEY, Dec. 11, 2024 SYDNEY, Dec. 11, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development, announced that data from two abstracts will be presented at the San Antonio Breast ...
PR Newswire FORT MYERS, Fla., Dec. 11, 2024 Results of first in-human trials highlighted at global symposium FORT MYERS, Fla., Dec. 11, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologists ...
Discover how a gut-on-chip device predicts melanoma patients' response to immunotherapy by simulating intestinal inflammation and microbiota interaction.
New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.
Vitamin E succinate has been found to inhibit tumor growth and enhance the effectiveness of immunotherapy by targeting critical elements of tumor development.
Discover how a simple saliva test offers a painless and reliable method for early oral cancer detection, potentially replacing invasive biopsies.
Discover why cancer cases have doubled in India since 1990. Learn about causes, prevention, and advancements in treatment.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers